Hyderabad-based Orbicular Pharmaceutical Technologies Receives U.S. FDA Tentative Approval for Generic Ozempic (Semaglutide Injection), in partnership with Apotex
Hyderabad, India, Apr 11th: Orbicular Pharmaceutical Technologies Pvt. Ltd., a Hyderabad–based leading developer of complex peptide-based generics, announced today that…
